Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali Том 7 № 2 (2022)

THE EVALUATION OF THE EFFECTIVENESS AND SAFETY OF THE USE OF FIXED TRIPLE ORAL SUGAR-REDUCING THERAPY WITH DEBISTAL-GM IN PATIENTS WITH TYPE 2 DIABETES WITH OBESITY

РАХИМОВА Гулнара Нишановна, АХРОРОВ Камиль Убайдуллаевич

Читать на сайте источника PDF

Аннотация

Given the complexity and versatility of the pathogenesis of type 2 diabetes, the choice of antihyperglycemic drugs is based on the importance of a simultaneous combined effect on several links in the pathogenesis of type 2 diabetes.  The aim of the study was to study the hypoglycemic efficacy, clinical tolerance and safety of Debistal-GM in obese patients with type 2 diabetes.  As a result of the study, high clinical efficacy, good tolerability and safety of Debistal-GM in obese type 2 diabetes were established. Inclusion criteria for the use of Debistal-GM are patients with type 2 diabetes with glycated hemoglobin values ​​above 9%, but below 11%; with a diabetes duration of more than 5 years, with a body mass index of more than 30 kg / m 2.  

сахарный диабет 2 типа, пиоглитазон, фиксированная комбинированная терапия СД 2 типа, трёхкомпонентная антигипер-гликемическая терапияtype 2 diabetes mellitus, pioglitazone, fixed combination therapy for type 2 diabetes, triple antihyperglycemic therapyқандли диабет 2-тур, пиоглитазон, ҚД 2-турнинг фиксацияланган комбинирланган давоси, уч таркибли антигипрегликемик даво

Источник метаданных: OAI-PMH архив журнала · Sindex не хранит полный текст, а даёт ссылку на источник.

Цитировать

APA 7 
РАХИМОВА Гулнара Нишановна & АХРОРОВ Камиль Убайдуллаевич (2022). THE EVALUATION OF THE EFFECTIVENESS AND SAFETY OF THE USE OF FIXED TRIPLE ORAL SUGAR-REDUCING THERAPY WITH DEBISTAL-GM IN PATIENTS WITH TYPE 2 DIABETES WITH OBESITY. Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(2).
GOST R 7.0.5 
РАХИМОВА Гулнара Нишановна, АХРОРОВ Камиль Убайдуллаевич THE EVALUATION OF THE EFFECTIVENESS AND SAFETY OF THE USE OF FIXED TRIPLE ORAL SUGAR-REDUCING THERAPY WITH DEBISTAL-GM IN PATIENTS WITH TYPE 2 DIABETES WITH OBESITY // Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali. 2022. Т. 7. № 2.
BibTeX 
@article{нишановна2022,
  author  = {РАХИМОВА Гулнара Нишановна and АХРОРОВ Камиль Убайдуллаевич},
  title   = {THE EVALUATION OF THE EFFECTIVENESS AND SAFETY OF THE USE OF FIXED TRIPLE ORAL SUGAR-REDUCING THERAPY WITH DEBISTAL-GM IN PATIENTS WITH TYPE 2 DIABETES WITH OBESITY},
  journal = {Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali},
  year    = {2022},
  volume  = {7},
  number  = {2}
}
RIS 
TY  - JOUR
AU  - РАХИМОВА Гулнара Нишановна
AU  - АХРОРОВ Камиль Убайдуллаевич
TI  - THE EVALUATION OF THE EFFECTIVENESS AND SAFETY OF THE USE OF FIXED TRIPLE ORAL SUGAR-REDUCING THERAPY WITH DEBISTAL-GM IN PATIENTS WITH TYPE 2 DIABETES WITH OBESITY
JO  - Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
PY  - 2022
VL  - 7
IS  - 2
ER  -